학술논문
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study
Document Type
Article
Author
Source
In The Lancet HIV August 2022 9(8):e544-e553
Subject
Language
ISSN
2352-3018